4-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)butan-1-ol | 159729-16-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: 4-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)butan-1-ol
• 英文别名: 4-[4-(1,2-Benzothiazol-3-yl)piperazin-1-yl]butan-1-ol
• CAS: 159729-16-5
• 化学式: C₁₅H₂₁N₃OS
• 分子量: 291.417
• InChiKey: QCNDMRQCQCCZMT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  20
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.53
• 拓扑面积：
  67.8
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  邻氨基苯甲酸 、 4-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)butan-1-ol 在 1,3-dicyclocarbodiimide 、 1-羟基苯并三唑一水物 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 20.0h， 以2.31 g的产率得到2-Amino-benzoic acid 4-(4-benzo[d]isothiazol-3-yl-piperazin-1-yl)-butyl ester
  参考文献：
  名称：

  Analogues of the potential antipsychotic agent 1192U90: amide modifications

  摘要：

  Analogues of 2-amino-N-(4-(4-(1, 2-benzisothiazol-3 -yl)-1-piperazinyl)-butyl)benzamide hydrochloride (1192U90) were prepared and evaluated in receptor binding assays for the dopamine D-2, serotonin 5-HT1a, and serotonin 5-HT2 receptors. Eight compounds have been synthesized in which the amide group of 1192U90 has been replaced with a variety of functional groups (i.e, ester, ketone, thioamide, butyramide, butyranilide, sulfonamide, alkoxyamide and hydrazide). These compounds exhibited moderate to potent affinities (0.55-200 nM) for all three receptors. Several analogues exhibited improved selectivity for the 5-HT2 receptor with D-2/5-HT2 binding ratios greater than 1192U90. (C) 1998 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0968-0896(98)00041-8
• 作为产物：
  描述：

  3-(1-哌嗪基)-1,2-苯并异噻唑 在 盐酸 、 三乙胺 作用下， 以 四氢呋喃 、 水 、 乙腈 为溶剂， 反应 45.0h， 生成 4-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)butan-1-ol
  参考文献：
  名称：

  Analogues of the potential antipsychotic agent 1192U90: amide modifications

  摘要：

  Analogues of 2-amino-N-(4-(4-(1, 2-benzisothiazol-3 -yl)-1-piperazinyl)-butyl)benzamide hydrochloride (1192U90) were prepared and evaluated in receptor binding assays for the dopamine D-2, serotonin 5-HT1a, and serotonin 5-HT2 receptors. Eight compounds have been synthesized in which the amide group of 1192U90 has been replaced with a variety of functional groups (i.e, ester, ketone, thioamide, butyramide, butyranilide, sulfonamide, alkoxyamide and hydrazide). These compounds exhibited moderate to potent affinities (0.55-200 nM) for all three receptors. Several analogues exhibited improved selectivity for the 5-HT2 receptor with D-2/5-HT2 binding ratios greater than 1192U90. (C) 1998 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0968-0896(98)00041-8

文献信息

• Succinimide Derivatives. II. Synthesis and Antipsychotic Activity of N-(4-(4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl)butyl)-1,2-cis-cyclohexanedicarboximide (SM-9018) and Related Compounds.
  作者：Kikuo ISHIZUMI、Atsuyuki KOJIMA、Fujio ANTOKU、Ikutaro SAJI、Mayumi YOSHIGI

  DOI：10.1248/cpb.43.2139

  日期：——

  Cyclic imides bearing omega-(4-benzisothiazol-3-yl-1-piperazinyl)alkyl moieties were synthesized and tested for antipsychotic activity. The in vitro binding affinities of these compounds were examined for dopamine 2 (D2) and serotonin 2 (5-HT2) receptor sites. Structure-activity relationships within these series are discussed. One of these compounds, N-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]-1

  合成带有ω-（4-苯并噻唑-3--3-基-1-哌嗪基）烷基的环状酰亚胺，并测试其抗精神病活性。检查这些化合物的体外结合亲和力对多巴胺2（D2）和血清素2（5-HT2）受​​体位点的影响。讨论了这些系列中的构效关系。发现其中一种化合物N- [4- [4-（1,2-苯并噻唑-3-基）-1-哌嗪基]丁基] -1,2-顺式环己基四甲酰亚胺（SM-9018）更多在体内，其抗精神病活性比噻螺酮更有效，更具选择性。SM-9018（17）目前正在作为选择性抗精神病药进行临床评估。
• Direct <i>N</i>-alkylation of sulfur-containing amines
  作者：Chen Li、Min-Tong Ge、Liang Bai、Ai-Bao Xia、Dan-Qian Xu、Zhen-Yuan Xu

  DOI：10.1039/d1ob00368b

  日期：——

  efficient ruthenium-catalyzed method has been developed for the direct N-alkylation of sulfur-containing amines with alcohols, for the first time, by a step-economical and environmentally friendly hydrogen borrowing strategy. The present methodology features base-free conditions and broad substrate scope, with water being the only by-product. Moreover, this protocol has been applied to the synthesis of the

  已经开发了一种高效的钌催化方法，用于通过逐步经济和环境友好的氢借用策略直接将含硫胺与醇进行N-烷基化。本方法的特点是无碱条件和广泛的底物范围，水是唯一的副产品。此外，该协议已应用于药物喹硫平的合成。